Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 4 Observational 1

Sponsor

Conditions

von Hippel-Lindau Disease 1

Interventions

Blood Specimen Collection 2 belzutifan 1 Exome Sequencing 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × von Hippel-Lindau Disease × belzutifan × Clear all

NCT06554730 2024-11-29

MK-6482-026

Merck Sharp & Dohme LLC

von Hippel-Lindau Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡